Results 31 to 40 of about 45,867 (252)

ERICA: smoking is associated with more severe asthma in Brazilian adolescents

open access: yesJornal de Pediatria (Versão em Português), 2019
Objective: To investigate the association between smoking and asthma, and possible associated factors in Brazilian adolescents. Methods: A cross‐sectional, national, school‐based study with adolescents aged 12–17 years, participants in the Study of ...
Erica Azevedo de Oliveira Costa Jordão   +7 more
doaj   +3 more sources

ASMA GRAVE

open access: yesRevistas Argentina de Medicina, 2022
Asma grave es el asma que requiere altas dosis de corticoesteroides inhalados (CI) en combinación con un segundo medicamento controlador para prevenir que el paciente pierda el control de la enfermedad o que permanezca sin control a pesar del ...
Sergio Zunino
doaj   +2 more sources

ASMA EQUINA GRAVE – REVISÃO DE LITERATURA

open access: goldAnais do IV Congresso Brasileiro de Práticas Veterinárias: Uma abordagem para animais de grande porte e produção animal
Alexandra Esteves, Ana Paula Santos
openalex   +2 more sources

Estado actual del uso de medicamentos biológicos en asma grave

open access: yesRevista Methodo, 2020
Asma es una enfermedad heterogénea que se manifiesta con diferentes fenotipos y endotipos de fisiopatología compleja. El asma grave resistente al tratamiento con altas dosis de esteroides inhalatorios es una entidad infrecuente pero que plantea un gran ...
Durán González A   +6 more
doaj   +1 more source

Dupilumab en el tratamiento del asma

open access: yesRevista Alergia México, 2021
Dupilumab es un anticuerpo monoclonal humano contra receptores de interleucina (IL)-4 e IL-4/IL-13. Estas son citocinas clave en la génesis de la inflamación tipo 2, predominante en los pacientes con asma. Los ensayos clínicos que evalúan la eficacia de
Said Eduardo Arablin-Oropeza   +5 more
doaj   +1 more source

Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma [PDF]

open access: yes, 2019
Objetivo: Mepolizumab está indicado como tratamiento adicional del asma eosinofílica refractaria grave. Las diferencias observadas en subgrupos poblacionales según recuento eosinofílico plasmático, existencia de pacientes con altos niveles de ...
Alarcón de la Lastra Romero, Catalina   +4 more
core   +3 more sources

Prevalence of symptoms of asthma, rhinitis, and atopic eczema among Brazilian children and adolescents identified by the International Study of Asthma and Allergies in Childhood (ISAAC): phase 3 [PDF]

open access: yes, 2006
OBJECTIVE: To determine the prevalence of symptoms of asthma, rhinitis, and atopic eczema among schoolchildren aged 6 to 7 years and adolescents aged 13 to 14 years in 20 Brazilian cities by using the standardized ISAAC written questionnaire, and to ...
Camelo-Nunes, Inês Cristina   +3 more
core   +3 more sources

Asma bronquial, enfermedad por reflujo gastroesofágico y hernia de hiato. A propósito de un caso [PDF]

open access: yesRevista SOCAMPAR, 2020
La asociación asma bronquial y enfermedad por reflujo gastroesofágico (ERGE) es muy común, sobre todo en pacientes con asma bronquial grave mal controlado. La relación tiene un carácter bidireccional.
Hurtado Fuentes A   +5 more
doaj  

The Portuguese Severe Asthma Registry: Development, Features, and Data Sharing Policies [PDF]

open access: yes, 2018
The Portuguese Severe Asthma Registry (Registo de Asma Grave Portugal, RAG) was developed by an open collaborative network of asthma specialists. RAG collects data from adults and pediatric severe asthma patients that despite treatment optimization and ...
Arrobas, A   +19 more
core   +1 more source

Why children with severe obstruction of the airway who are attended in the emergency department are different [PDF]

open access: yes, 2001
Universidade Federal de São Paulo (UNIFESP) Escola Paulista de Medicina Departamento de Pediatriado Hospital Beneficência Portuguesa UCI PediátricaHospital Santa Catarina de São Paulo UCI PediátricaUNIFESP, EPM, Depto.
Carvalho, Werther Brunow de
core   +2 more sources

Home - About - Disclaimer - Privacy